Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CartiMax is a nutritional supplement and nutraceutical primarily used to manage symptoms of osteoarthritis. Its primary active ingredient is glucosamine sulphate, an amino sugar that serves as a critical precursor in the biosynthesis of glycosaminoglycans, which are essential components of joint cartilage. By providing the building blocks for cartilage repair and stimulating the production of synovial fluid, CartiMax helps to maintain joint lubrication, improve flexibility, and reduce pain and inflammation associated with degenerative joint diseases. It is manufactured by several companies, including Pharmed and Nutramed Pharmaceuticals, and is available in various strengths, sometimes in combination with other joint-supportive ingredients like chondroitin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CartiMax.